Whose costs and benefits? Why economic evaluations should simulate both prevalent and all future incident patient cohorts.

Abstract

Most health technology economic evaluations simulate only the prevalent cohort or the next incident cohort of patients. They therefore do not capture all future patient-related benefits and costs.